125.00
0.00%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Hi-Clearance
Its shares trade on Taipei Exchange under the ticker 1788.TWO. It has been listed since 10 September 2004. In the fiscal year to 31 December 2025, it reported revenue of TWD 4.28bn and net income of TWD 368.5m. At that date it held total assets of TWD 5.08bn and shareholders' equity of TWD 3.05bn.
Hi-Clearance, Inc. is engaged in the supply of medical equipment and consumables. The company is headquartered in Taipei, New Taipei. The company went IPO on 2004-09-10. The firm's main products include artificial kidneys, kidney dialysis machines, blood circuit tubes, nutritional products for chronic kidney diseases, erythropoietin, cardiology products, medicinal liquid, dental and stomatology products, home health products and others. The firm also provides medical equipment maintenance services. The firm distributes its products mainly in domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 10 Sept 2004
- Website
- hiclearance.com.tw ↗
Leadership
Pay as last reported
- Mr. Chung-Liang LeeChairman of the Board, since 2016
- Mr. Guoshi ChenGeneral Manager, Director, since 1995TWD 4.3m
- Ms. Yingfen LiDeputy General Manager-General Management Division, Director, since 2002
- Yaoyuan ZhangHead of Accounting, Corporate Governance Officer
- Bilin CaiDirector
- Mr. Bingchang ChenDirector
- Mr. Bingxun JiangDirector
- Mr. Shy-Lou LeeDirector
- Kuntai LiaoDirector
- Mr. Yunming WuDirector, since 2010
- Zhicheng JianIndependent Director
- Yongchang WangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Hi-Clearance Inc supplies artificial kidneys and dialysis machines in Taipei, Taiwan.
- The company offers kidney dialysis machines and blood circuit tubes for chronic kidney disease patients.
- Hi-Clearance provides medical equipment maintenance services across Taiwan's domestic market.
Weaknesses
- Hi-Clearance's main products are limited to medical equipment and consumables in Taiwan.
- The firm's distribution is restricted to the domestic market in Taiwan only.
- Hi-Clearance focuses on medical equipment without expanding into international markets.
Opportunities
- Hi-Clearance can expand its medical equipment distribution to other Asian countries.
- The growing demand for chronic kidney disease products presents new market opportunities.
- Increasing healthcare spending in Taiwan supports potential growth for medical equipment suppliers.
Threats
- Competition from domestic medical equipment suppliers in Taiwan poses a threat.
- Regulatory changes in Taiwan's healthcare sector could impact operations.
- Economic downturns in Taiwan may reduce healthcare spending and affect sales.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.